Binding mechanism of the tyrosine-kinase
inhibitor nilotinib to human serum albumin determined by H-1 STD NMR, F-19 NMR,
and molecular modeling
Yan, J (Yan, Jin)[ 1 ] ; Wu, D (Wu, Di)[ 1 ] ; Sun, PC (Sun, Pingchuan)[ 2 ] ; Ma, XL (Ma, Xiaoli)[ 1 ] ; Wang, LL (Wang, Lili)[ 1 ] ; Li, SS (Li, Shanshan)[ 1 ] ;Xu, KL (Xu, Kailin)[ 1 ] ; Li, H (Li, Hui)[ 1 ]
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
2016, 124: 1-9
DOI: 10.1016/j.jpba.2016.02.024
WOS:000374202000001
